top of page


Data & Analytics Highlighting Industry Stats, Trends, Analogs, Company Profiles, and Key Insights
Pipeline & Launch Analytics
Legal Analytics
Pricing, Access, Rebate, & Sales Analytics
IPD's Data STACK subscriptions support decision-making with curated datasets and visualizations, expert analytics, easy-to-use analog generators, and trend reports in these impactful coverage areas:
Pipeline & Launch Analytics
-
Brand Clinical Development Analytics
-
Brand Drug Approvals
-
ANDA Filing & Timing Analytics
-
Generic Pipeline & Launch Analytics
-
Authorized Generics Launch Analytics
-
Generic Launch Analogs & CI
-
At-Risk Generic Launch Analytics
-
Trend Reports
Legal Analytics
-
IPR Analytics
-
EPO Opposition Analytics
-
US District Court Analytics
-
EU National Litigation Analytics
-
Settlement Analytics
-
Legal Decision Timing Analytics
-
Trend Reports
-
Sales and Rebate Analytics
-
Epidemiology Analytics
-
Formulary Analytics
-
Limited Distribution Analytics
-
Global Health Technology Assessments
-
Therapy Cost Search
-
Therapy Cost Analytics
-
Hospital Pricing Benchmarks
-
Trend Reports
Pricing, Access, Rebate, & Sales Analytics
Explore Recent Reports
December 2025
U.S. Insights: Top 20 Small-Molecule Brand Drugs Facing Generic Competition by Year-End 2026
IPD Analytics has released a new Data STACK Trend Report, “U.S. Insights: Top 20 Small-Molecule Brand Drugs Facing Generic Competition by Year-End 2026.” This report examines the top 20 small-molecule brand drugs, including 13 blockbuster products, that may face first-time generic competition by the end of 2026.
bottom of page
